Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1996-2-20
pubmed:abstractText
Chimeric proteins were constructed from pyocin S1 or S2 and colicin E3 or E2, and their characteristics were investigated with special reference to the domain structure. The nuclease domains were interchangeable between two bacteriocins so that a new kind of pyocin, with RNase activity, was created. A bacteriocin which can kill both Pseudomonas aeruginosa and Escherichia coli was also constructed. Investigations with various chimeric proteins indicate that the translocation domain as well as the receptor-binding domain is species specific. Inhibition of lipid synthesis, which is characteristic of pyocins, was also observed with chimeric pyocins carrying the DNase domain of colicin E2 but not with those carrying the RNase domain of E3. Thus, the DNase domain is responsible for the inhibition of lipid synthesis.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8550402-1069283, http://linkedlifedata.com/resource/pubmed/commentcorrection/8550402-113383, http://linkedlifedata.com/resource/pubmed/commentcorrection/8550402-3290201, http://linkedlifedata.com/resource/pubmed/commentcorrection/8550402-3516985, http://linkedlifedata.com/resource/pubmed/commentcorrection/8550402-368047, http://linkedlifedata.com/resource/pubmed/commentcorrection/8550402-3889348, http://linkedlifedata.com/resource/pubmed/commentcorrection/8550402-3892228, http://linkedlifedata.com/resource/pubmed/commentcorrection/8550402-4860260, http://linkedlifedata.com/resource/pubmed/commentcorrection/8550402-4907332, http://linkedlifedata.com/resource/pubmed/commentcorrection/8550402-4930442, http://linkedlifedata.com/resource/pubmed/commentcorrection/8550402-4976694, http://linkedlifedata.com/resource/pubmed/commentcorrection/8550402-6282695, http://linkedlifedata.com/resource/pubmed/commentcorrection/8550402-6371470, http://linkedlifedata.com/resource/pubmed/commentcorrection/8550402-6444517, http://linkedlifedata.com/resource/pubmed/commentcorrection/8550402-6783626, http://linkedlifedata.com/resource/pubmed/commentcorrection/8550402-811653, http://linkedlifedata.com/resource/pubmed/commentcorrection/8550402-8384291, http://linkedlifedata.com/resource/pubmed/commentcorrection/8550402-8407790, http://linkedlifedata.com/resource/pubmed/commentcorrection/8550402-8423163, http://linkedlifedata.com/resource/pubmed/commentcorrection/8550402-8491711
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Bacterial Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Bacteriocins, http://linkedlifedata.com/resource/pubmed/chemical/Colicins, http://linkedlifedata.com/resource/pubmed/chemical/Deoxyribonucleases, http://linkedlifedata.com/resource/pubmed/chemical/Escherichia coli Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Phospholipids, http://linkedlifedata.com/resource/pubmed/chemical/Pyocins, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cell Surface, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Ribonucleases, http://linkedlifedata.com/resource/pubmed/chemical/colicin receptor, E coli, http://linkedlifedata.com/resource/pubmed/chemical/pyocin S1
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0021-9193
pubmed:author
pubmed:issnType
Print
pubmed:volume
178
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
103-10
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
Construction and characterization of pyocin-colicin chimeric proteins.
pubmed:affiliation
Misubishi Kasei Institute of Life Sciences, Tokyo, Japan.
pubmed:publicationType
Journal Article